4-Methoxyamphetamine

No registered brands found for this active ingredient.

No food notes on record for this active ingredient.

• OliceridineMAJOR

  The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when 4-Methoxyamphetamine is combined with Oliceridine.

  Expert view
• 2,5-Dimethoxy-4-ethylamphetamineMODERATE

  The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with 4-Methoxyamphetamine.

  Expert view
• 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidineMODERATE

  The metabolism of 4-Methoxyamphetamine can be decreased when combined with 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine.

  Expert view
• 1-benzylimidazoleMODERATE

  The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with 1-benzylimidazole.

  Expert view
• 1,2-BenzodiazepineMODERATE

  The risk or severity of CNS depression can be increased when 4-Methoxyamphetamine is combined with 1,2-Benzodiazepine.

  Expert view
• 2,5-Dimethoxy-4-ethylthioamphetamineMODERATE

  The risk or severity of CNS depression can be increased when 4-Methoxyamphetamine is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.

  Expert view
• 4-Bromo-2,5-dimethoxyamphetamineMODERATE

  The risk or severity of CNS depression can be increased when 4-Methoxyamphetamine is combined with 4-Bromo-2,5-dimethoxyamphetamine.

  Expert view
• 5-methoxy-N,N-dimethyltryptamineMODERATE

  The risk or severity of CNS depression can be increased when 4-Methoxyamphetamine is combined with 5-methoxy-N,N-dimethyltryptamine.

  Expert view
• 7-NitroindazoleMODERATE

  The risk or severity of CNS depression can be increased when 4-Methoxyamphetamine is combined with 7-Nitroindazole.

  Expert view
• 7,8-Dichloro-1,2,3,4-tetrahydroisoquinolineMODERATE

  7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypertensive activities of 4-Methoxyamphetamine.

  Expert view